Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
9-((5S,8S,14S,17S,20S,29S)-8-benzyl-14-sec-butyl-5,17,20,29-tetraisopropyl-2,2,11,11,23,23-hexamethyl-4,7,10,13,16,19,22,25,28,31-decaoxo-3,6,9,12,15,18,21,24,27,30-decaazadotriacontanamido)-N-((3S,6S,11R,12S,15S)-9,12-dibenzyl-3-carbamoyl-11-hydroxy-6-isobutyl-2,16-dimethyl-5,8,14-trioxo-4,7,9,13-tetraazaheptadecan-15-yl)nonanamide
ID: ALA4874349
PubChem CID: 164626299
Max Phase: Preclinical
Molecular Formula: C94H151N17O17
Molecular Weight: 1791.34
Molecule Type: Unknown
Associated Items: